BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24052410)

  • 1. MicroRNA-29a protects against acute liver injury in a mouse model of obstructive jaundice via inhibition of the extrinsic apoptosis pathway.
    Tiao MM; Wang FS; Huang LT; Chuang JH; Kuo HC; Yang YL; Huang YH
    Apoptosis; 2014 Jan; 19(1):30-41. PubMed ID: 24052410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-29a mitigation of endoplasmic reticulum and autophagy aberrance counteracts in obstructive jaundice-induced fibrosis in mice.
    Huang YH; Yang YL; Huang FC; Tiao MM; Lin YC; Tsai MH; Wang FS
    Exp Biol Med (Maywood); 2018 Jan; 243(1):13-21. PubMed ID: 29105510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-29a mitigation of toll-like receptor 2 and 4 signaling and alleviation of obstructive jaundice-induced fibrosis in mice.
    Lin YC; Wang FS; Yang YL; Chuang YT; Huang YH
    Biochem Biophys Res Commun; 2018 Feb; 496(3):880-886. PubMed ID: 29366780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of Mir-29a in Activated Hepatic Stellate Cells Modulates Its Profibrogenic Phenotype through Inhibition of Histone Deacetylases 4.
    Huang YH; Tiao MM; Huang LT; Chuang JH; Kuo KC; Yang YL; Wang FS
    PLoS One; 2015; 10(8):e0136453. PubMed ID: 26305546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-29a Alleviates Bile Duct Ligation Exacerbation of Hepatic Fibrosis in Mice through Epigenetic Control of Methyltransferases.
    Yang YL; Wang FS; Li SC; Tiao MM; Huang YH
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-29a is a key regulon that regulates BRD4 and mitigates liver fibrosis in mice by inhibiting hepatic stellate cell activation.
    Huang YH; Kuo HC; Yang YL; Wang FS
    Int J Med Sci; 2019; 16(2):212-220. PubMed ID: 30745801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous Therapeutics of Microrna-29a Attenuates Development of Hepatic Fibrosis in Cholestatic Animal Model through Regulation of Phosphoinositide 3-Kinase p85 Alpha.
    Yang YL; Wang FS; Lin HY; Huang YH
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microarray Study of Pathway Analysis Expression Profile Associated with MicroRNA-29a with Regard to Murine Cholestatic Liver Injuries.
    Li SC; Wang FS; Yang YL; Tiao MM; Chuang JH; Huang YH
    Int J Mol Sci; 2016 Mar; 17(3):324. PubMed ID: 26938532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogen-rich saline protects against mitochondrial dysfunction and apoptosis in mice with obstructive jaundice.
    Liu Q; Li BS; Song YJ; Hu MG; Lu JY; Gao A; Sun XJ; Guo XM; Liu R
    Mol Med Rep; 2016 Apr; 13(4):3588-96. PubMed ID: 26936224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-1 antitrypsin Z protein (PiZ) increases hepatic fibrosis in a murine model of cholestasis.
    Mencin A; Seki E; Osawa Y; Kodama Y; De Minicis S; Knowles M; Brenner DA
    Hepatology; 2007 Nov; 46(5):1443-52. PubMed ID: 17668872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of microRNA-29 by antisense inhibitors and a PPAR-gamma agonist protects against myocardial ischaemia-reperfusion injury.
    Ye Y; Hu Z; Lin Y; Zhang C; Perez-Polo JR
    Cardiovasc Res; 2010 Aug; 87(3):535-44. PubMed ID: 20164119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepcidin protects against lipopolysaccharide-induced liver injury in a mouse model of obstructive jaundice.
    Huang YH; Yang YL; Tiao MM; Kuo HC; Huang LT; Chuang JH
    Peptides; 2012 Jun; 35(2):212-7. PubMed ID: 22504010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antinecrotic and antiapoptotic effects of hepatocyte growth factor on cholestatic hepatitis in a mouse model of bile-obstructive diseases.
    Li Z; Mizuno S; Nakamura T
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G639-46. PubMed ID: 17068118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury.
    Tamaki N; Hatano E; Taura K; Tada M; Kodama Y; Nitta T; Iwaisako K; Seo S; Nakajima A; Ikai I; Uemoto S
    Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G498-505. PubMed ID: 18174271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biliary intervention aggravates cholestatic liver injury, and induces hepatic inflammation, proliferation and fibrogenesis in BDL mice.
    Wen YA; Liu D; Zhou QY; Huang SF; Luo P; Xiang Y; Sun S; Luo D; Dong YF; Zhang LP
    Exp Toxicol Pathol; 2011 Mar; 63(3):277-84. PubMed ID: 20149605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma biomarkers of liver injury and inflammation demonstrate a lack of apoptosis during obstructive cholestasis in mice.
    Woolbright BL; Antoine DJ; Jenkins RE; Bajt ML; Park BK; Jaeschke H
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):524-31. PubMed ID: 24096036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of the red wine polyphenol resveratrol on a rat model of biliary obstructed cholestasis: involvement of anti-apoptotic signalling, mitochondrial biogenesis and the induction of autophagy.
    Lin TK; Huang LT; Huang YH; Tiao MM; Tang KS; Liou CW
    Apoptosis; 2012 Aug; 17(8):871-9. PubMed ID: 22562605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-29a Suppresses CD36 to Ameliorate High Fat Diet-Induced Steatohepatitis and Liver Fibrosis in Mice.
    Lin HY; Wang FS; Yang YL; Huang YH
    Cells; 2019 Oct; 8(10):. PubMed ID: 31652636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miRNA-21 ablation protects against liver injury and necroptosis in cholestasis.
    Afonso MB; Rodrigues PM; Simão AL; Gaspar MM; Carvalho T; Borralho P; Bañales JM; Castro RE; Rodrigues CMP
    Cell Death Differ; 2018 May; 25(5):857-872. PubMed ID: 29229992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of apoptosis by the intrinsic but not the extrinsic apoptotic pathway in myocardial ischemia-reperfusion.
    Kristen AV; Ackermann K; Buss S; Lehmann L; Schnabel PA; Haunstetter A; Katus HA; Hardt SE
    Cardiovasc Pathol; 2013; 22(4):280-6. PubMed ID: 23410819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.